Monthly high-dose cholecalciferol supplementation in prostate cancer patients (ProsD trial): A nested analysis of vitamin D metabolites, metabolic ratios, and biochemical safety
Publication date: December 2026 Source: Cancer Epidemiology, Volume 105 Author(s): Chifeng Tan, Michael C. David, Paul H. Anderson, Rebecca S. Mason, David R. Fraser, Michael G. Kimlin, Rebecca K. Sawyer, Marzieh Amirmostofian, Mark Frydenberg, John W. Yaxley, David Gillatt, Henry Woo, Prem Rashid, Robert ‘Frank’ Gardiner, Krishan Rasiah, Manish I. Patel, Howard Gurney, David P. Smith, Visalini Nair-Shalliker
Monthly high-dose cholecalciferol supplementation in prostate cancer patients (ProsD trial): A nested analysis of vitamin D metabolites, metabolic ratios, and biochemical safety. // Cancer Epidemiology. – URL: https://www.sciencedirect.com/science/article/pii/S1877782126002742?dgcid=rss_sd_all
Monthly high-dose cholecalciferol supplementation in prostate cancer patients (ProsD trial): A nested analysis of vitamin D metabolites, metabolic ratios, and biochemical safety. Cancer Epidemiology. https://www.sciencedirect.com/science/article/pii/S1877782126002742?dgcid=rss_sd_all
“Monthly high-dose cholecalciferol supplementation in prostate cancer patients (ProsD trial): A nested analysis of vitamin D metabolites, metabolic ratios, and biochemical safety.” Cancer Epidemiology.
@article{article39506,
title = {Monthly high-dose cholecalciferol supplementation in prostate cancer patients (ProsD trial): A nested analysis of vitamin D metabolites, metabolic ratios, and biochemical safety},
journal = {Cancer Epidemiology},
url = {https://www.sciencedirect.com/science/article/pii/S1877782126002742?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment